GetTopicDetailResponse(id=521095e2511, topicName=重型癲癇, introduction=重型癲癇, content=null, image=null, comments=2, allHits=1619, url=https://h5.medsci.cn/topic?id=95725, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=1351, tagList=[TagDto(tagId=1351, tagName=重型癲癇)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2123798, encodeId=9f522123e9808, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>批準(zhǔn)<a href='/topic/show?id=05c0105e807c' target=_blank style='color:#2F92EE;'>#氯巴占#</a>（clobazam）治療<a href='/topic/show?id=521095e2511' target=_blank style='color:#2F92EE;'>#重型癲癇#</a><a href='/topic/show?id=78b298640cb' target=_blank style='color:#2F92EE;'>#難治性癲癇#</a>, objectTitle=FDA批準(zhǔn)氯巴占（clobazam）治療重型癲癇, objectType=article, longId=3260, objectId=3ea83260c5, topicUrl=null, isHasObj=0, objectCover=, objectUrl=/article/show_article.do?id=3ea83260c5, replyNumber=0, likeNumber=152, createdTime=2023-04-05, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3ea83260c5, moduleTitle=FDA批準(zhǔn)氯巴占（clobazam）治療重型癲癇, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3ea83260c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945429, encodeId=615819454297c, content=<a href='/topic/show?id=521095e2511' target=_blank style='color:#2F92EE;'>#重型癲癇#</a>, objectTitle=FDA批準(zhǔn)氯巴占（clobazam）治療重型癲癇, objectType=article, longId=3260, objectId=3ea83260c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ea83260c5, replyNumber=0, likeNumber=103, createdTime=2011-12-21, rootId=0, userName=zz12341234, userId=62e4433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ea83260c5, moduleTitle=FDA批準(zhǔn)氯巴占（clobazam）治療重型癲癇, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3ea83260c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
